Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -405.51% is 138% below its 5-year average of -170.18%, near the low end of its 5-year range (-461.93%–-43.83%).
As of the fiscal period ended Tuesday, June 30, 2026. 10.28% below its 12-month average of -367.71%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -405.51%.
RETURN ON EQUITY (ROE)
-405.51%
RETURN ON EQUITY (ROE) AVG TTM
-367.71%
RETURN ON EQUITY (ROE) AVG 3Y
-249.98%
RETURN ON EQUITY (ROE) AVG 5Y
-170.18%
RETURN ON EQUITY (ROE) AVG 10Y
-123.23%
RETURN ON EQUITY (ROE) AVG 15Y
-85.62%
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-10.28%
CURRENT VS 3Y AVG
-62.22%
CURRENT VS 5Y AVG
-138.28%
CURRENT VS 10Y AVG
-229.08%
CURRENT VS 15Y AVG
-373.63%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 753 covered companies
CURRENT VS SECTOR MEDIAN
-865.27%
vs the sector median at left
Verastem, Inc.
Market Cap
$681.02M
Return on Equity (ROE)
-405.51%
TTM Avg
-367.71%
3Y Avg
-249.98%
5Y Avg
-170.18%
Market Cap
$681.27M
Return on Equity (ROE)
-55.36%
TTM Avg
-93.85%
3Y Avg
-76.06%
5Y Avg
-67.62%
Market Cap
$685.49M
Return on Equity (ROE)
-41.20%
TTM Avg
50554.28%
3Y Avg
25132.94%
5Y Avg
16622.35%
Market Cap
$673.41M
Return on Equity (ROE)
2.89%
TTM Avg
20.45%
3Y Avg
11.91%
5Y Avg
-3.26%
Market Cap
$691.79M
Return on Equity (ROE)
-47.51%
TTM Avg
-32.80%
3Y Avg
-39.18%
5Y Avg
-31.37%
Market Cap
$693.19M
Return on Equity (ROE)
-113.05%
TTM Avg
-95.98%
3Y Avg
-72.88%
5Y Avg
-73.85%
Market Cap
$693.61M
Return on Equity (ROE)
-44.64%
TTM Avg
-42.57%
3Y Avg
32.15%
5Y Avg
-68.82%
Market Cap
$694.79M
Return on Equity (ROE)
-25.03%
TTM Avg
-10.49%
3Y Avg
-5.87%
5Y Avg
-23.97%
Market Cap
$666.95M
Return on Equity (ROE)
-75.79%
TTM Avg
-55.51%
3Y Avg
-59.06%
5Y Avg
-60.41%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Verastem, Inc. (VSTM) | $681.02M | -405.51% | -367.71% | -249.98% | -170.18% |
| Solid Biosciences Inc. (SLDB)vs › | $681.27M | -55.36% | -93.85% | -76.06% | -67.62% |
| Anteris Technologies Global Corp. (AVR)vs › | $685.49M | -41.20% | 50554.28% | 25132.94% | 16622.35% |
| MiMedx Group, Inc. (MDXG)vs › | $673.41M | 2.89% | 20.45% | 11.91% | -3.26% |
| Olema Pharmaceuticals, Inc. (OLMA)vs › | $691.79M | -47.51% | -32.80% | -39.18% | -31.37% |
| Faeth Therapeutics, Inc. (FTH)vs › | $693.19M | -113.05% | -95.98% | -72.88% | -73.85% |
| Wave Life Sciences Ltd. (WVE)vs › | $693.61M | -44.64% | -42.57% | 32.15% | -68.82% |
| Cytek Biosciences, Inc. (CTKB)vs › | $694.79M | -25.03% | -10.49% | -5.87% | -23.97% |
| Helus Pharma Inc. (HELP)vs › | $666.95M | -75.79% | -55.51% | -59.06% | -60.41% |
| Annexon, Inc. (ANNX)vs › | $660.29M | -108.93% | -72.41% | -64.95% | -55.74% |
ROE
-405.5%
ROA
-98.2%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -405.51% |
| 2026-03-31 | -237.18% |
| 2025-12-31 | -366.23% |
| 2025-06-30 | -461.93% |
| 2024-09-30 | -290.06% |
| 2024-06-30 | -223.67% |
| 2024-03-31 | -228.29% |
| 2023-12-31 | -152.28% |
| 2023-09-30 | -73.61% |
| 2023-06-30 | -61.01% |
| 2023-03-31 | -133.92% |
| 2022-12-31 | -155.75% |
| 2022-09-30 | -116.88% |
| 2022-06-30 | -145.07% |
| 2022-03-31 | -100.49% |
| 2021-12-31 | -81.32% |
| 2021-09-30 | -77.97% |
| 2021-06-30 | -43.83% |
| 2021-03-31 | -43.63% |
| 2020-12-31 | -58.75% |
| 2020-09-30 | -66.76% |
| 2020-06-30 | -113.59% |
| 2020-03-31 | -121.23% |
| 2019-09-30 | -565.99% |
| 2019-06-30 | -229.81% |
| 2019-03-31 | -101.16% |
| 2018-12-31 | -58.27% |
| 2018-09-30 | -73.71% |
| 2018-06-30 | -63.67% |
| 2018-03-31 | -196.74% |
| 2017-12-31 | -117.54% |
| 2017-09-30 | -149.38% |
| 2017-06-30 | -95.41% |
| 2017-03-31 | -68.05% |
| 2016-12-31 | -50.40% |
| 2016-09-30 | -44.46% |
| 2016-06-30 | -49.59% |
| 2016-03-31 | -53.12% |
| 2015-12-31 | -56.47% |
| 2015-09-30 | -53.41% |
| 2015-06-30 | -46.17% |
| 2015-03-31 | -42.06% |
| 2014-12-31 | -60.12% |
| 2014-09-30 | -57.13% |
| 2014-06-30 | -48.40% |
| 2014-03-31 | -41.37% |
| 2013-12-31 | -35.08% |
| 2013-09-30 | -29.83% |
| 2013-06-30 | -50.31% |
| 2013-03-31 | -41.23% |
| 2012-12-31 | -35.35% |
| 2012-09-30 | -31.45% |
| 2012-06-30 | -23.20% |
| 2012-03-31 | -18.02% |
| 2011-12-31 | -24.71% |
